2 Top Biotech Stocks to Buy Right Now
Promising industry prospects and company quality are two components that are vital to successful long-term investing. If an industry isn't able to steadily grow, stocks in that industry likely won't either. And quality is important because below-average stocks in fast-growing industries often aren't able to capitalize on that expansion.
Thanks to a growing and aging world population, it's estimated that the global pharmaceutical industry will grow at a 5.7% annual clip from $1.1 trillion in 2022 to $1.4 trillion by 2026. Here are two top-notch, cheaply valued pharma stocks to consider buying now.
The first pharma stock to think about purchasing right now is Amgen (NASDAQ: AMGN). With a $136 billion market capitalization, Amgen is the 11th-largest pharma stock in the world.
Source Fool.com
